Nomogram Predicting Lymph Node Metastasis in the Early-Stage Cervical Cancer
Shimin Yang1, Chunli Liu2, Chunbo Li1
1Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Frontiers in Medicine
|July 18, 2022
Summary
This study developed a new nomogram using 18F-FDG PET/CT scans and clinical data to predict lymph node metastasis in early cervical cancer patients, aiding surgical decisions.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Accurate prediction of lymph node metastasis is crucial for managing early-stage cervical cancer.
- 18F-FDG PET/CT imaging offers potential for risk stratification.
- Identifying high-risk patients aids in tailoring treatment strategies.
Purpose of the Study:
- To develop and validate a predictive nomogram for lymph node metastasis in early cervical cancer.
- To integrate 18F-FDG PET/CT findings with clinical characteristics.
- To improve pre-operative risk assessment for cervical cancer patients.
Main Methods:
- Retrospective review of 234 early-stage cervical cancer patients (FIGO 2018 IA-IIA) who underwent 18F-FDG PET/CT before surgery.
- Construction of a nomogram using predictors like SCCA, nSUVmax, uterine corpus invasion, and tumor size.
- Internal and external validation using a separate cohort of 191 patients.
Main Results:
- A nomogram incorporating squamous cell carcinoma antigen (SCCA), lymph node SUVmax (nSUVmax), uterine corpus invasion, and tumor size was developed.
- The nomogram achieved high predictive accuracy with an area under the ROC curve of 0.926 (primary) and 0.897 (validation).
- Calibration and decision curve analyses confirmed the nomogram's good agreement and clinical utility.
Conclusions:
- A simple and effective nomogram for predicting lymph node metastasis in cervical cancer has been established and validated.
- This tool can assist clinicians in pre-operative risk assessment for early-stage cervical cancer.
- The nomogram enhances personalized treatment planning by identifying metastasis risk.


